Search

Christiane Kuhl Julie Gralow MRI Better Than Mammography for Detecting High-Grade Ductal Carcinoma In Situ? REFERENCE: 1504, ASCO Annual Meeting Chicago June 1-5, 2007 CHRISTIANE KUHL, University of B

Aimery de Gramont Robert Mayer MOSAIC Study Six Year Results: Adjuvant Oxaliplatin Adds Survival Advantage for Patients with Stage III Colorectal Cancer REFERENCE: 4007, ASCO Annual Meeting Chicago Ju

Josep Llovet Robert Mayer Sorafenib The ‘New Standard’ for Advanced Liver Cancer REFERENCE: ABSTRACT 5 (Plenary Session), ASCO Annual Meeting Chicago June 1-5, 2007 JOSEP LLOVET, IDIBAPS H

Bernard Escudier Dean Bajorin Bevacizumab in Advanced Kidney Cancer: Another Treatment Gives Benefit in First Line REFERENCE: ABSTRACT 3, ASCO Annual Meeting Chicago June 1-5, 2007 BERNARD ESCUDIER, G

Ben Slotman Roy Herbst Prophylactic Cranial Irradiation: Fewer Brain Metastases, Longer Survival for Patients with Small Cell Lung Cancer REFERENCE: ABSTRACT 4, ASCO Annual Meeting Chicago June 1-5, 2

Lawrence Wickerham Invasive Breast Cancer Chemoprevention Trials Assessed REFERENCE: ABSTRACT Special Session; American Association for Cancer Research Centennial Meeting, April 14-18, Los Angeles LAW

LISA McNALLY, Institute of Child Health, London, and University of KwaZulu-Natal, Durban REFERENCE: The Lancet 2007; 369:1440-1451 A new study suggests that current guidelines for the treatment of sev

NICHOLAS GRASSLY, Imperial College London REFERENCE: Lancet 2007; 369:1356-62 A case-control study performed in India has provided hope that polio could finally be eradicated. India is one of six coun

ANTHONY FAUCI, National Institutes of Health, Bethesda REFERENCE: N Engl J Med 2007;356:2073-81 Is there any hope for an HIV vaccine? According to Anthony Fauci, of the National Institutes of Health i

Alberto Sobrero Cetuximab With Irinotecan: Phase III Study Shows Benefit in Patients with Oxaliplatin-Refractory Colorectal Cancer REFERENCE: ABSTRACT LB-2; AACR 2007, Los Angeles, Plenary Session ALB

HARVEY WHITE, Auckland City Hospital, New Zealand REFERENCE: European Heart Journal Advanced On-Line Publication April 24th, 2007 Enoxaparin could be the new standard anti-thrombotic therapy for patie

JAIME MIRANDA, London School of Hygiene and Tropical Medicine, Peru An antifibrinolytic agent, tranexamic acid (commonly used to reduce bleeding during surgery) is being investigated as first-aid to c